1 Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium.
Nature 1999; 401: 921-923
2 Shiina T, Tamiya G, Oka A, Takishima N, Yamagata T, Kikkawa E, Iwata K, Tomizawa M, Okuaki N, Kuwano Y,
Watanabe K, Fukuzumi Y, Itakura S, Sugawara C, Ono A, Yamazaki M, Tashiro H, Ando A, Ikemura T, Soeda E, Kimura
M, Bahram S, Inoko H. Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1,796,938-bp HLA
class I region. Proc Natl Acad Sci USA 1999; 96: 13282-13287
3 Gleeson MH, Walker JS, Wentzel J, Chapman JA, Harris R. Human leucocyte antigens in Crohn's disease and ulcerative
colitis. Gut 1972; 13: 438-440
4 Ma Y, Ohmen JD, Li Z, Bentley LG, McElree C, Pressman S, Targan SR, Fischel-Ghodsian N, Rotter JI, Yang H. A
genome-wide search identifies potential new susceptibility loci for Crohn's disease. Inflamm Bowel Dis 1999; 5: 271-
278
5 Hampe J, Schreiber S, Shaw SH, Lau KF, Bridger S, Macpherson AJ, Cardon LR, Sakul H, Harris TJ, Buckler A, Hall J,
Stokkers P, van Deventer SJ, Nurnberg P, Mirza MM, Lee JC, Lennard-Jones JE, Mathew CG, Curran ME. A genomewide
analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum
Genet 1999; 64: 808-816
6 Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer
S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S. Linkage of
inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 1999; 65: 1647-1655
7 Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, Green T, Brettin TS, Stone V, Bull SB, Bitton
A, Williams CN, Greenberg GR, Cohen Z, Lander ES, Hudson TJ, Siminovitch KA. Genomewide search in Canadian
families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863-1870
8 Dechairo B, Dimon C, van Heel D, Mackay I, Edwards M, Scambler P, Jewell D, Cardon L, Lench N, Carey A. Replication
and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3).
Eur J Hum Genet 2001; 9: 627-633
9 Panhuysen CI, Cavanaugh J, Yang H, Barmada MM, Vermeire S, Rotter J, Paavola P, Hampe J, Annese V, Jewell D,
Duerr R, Radford-Smith G, O'Callaghan N, Brant S, Silverberg M, Cho J, Hugot JP, Consortium ftIIG. TNF - 857 promoter
polymorphism is a significant risk factor for IBD and shows epistasis with NOD2/ CARD15 Crohn's disease predisposing
mutations. IBD in Press 2005
10 van Heel DA, Fisher SA, Kirby A, Daly MJ, Rioux JD, Lewis CM. Inflammatory bowel disease susceptibility loci defined by
genome scan meta-analysis of 1952 affected relative pairs. Hum Mol Genet 2004; 13: 763-770
11 Yang H, Plevy SE, Taylor K, Tyan D, Fischel-Ghodsian N, McElree C, Targan SR, Rotter JI. Linkage of Crohn's disease to
the major histocompatibility complex region is detected by multiple non-parametric analyses.Gut 1999; 44: 519-526
12 Satsangi J, Welsh KI, Bunce M, Julier C, Farrant JM, Bell JI, Jewell DP. Contribution of genes of the major
histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347:
1212-1217
13 Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL. Phenotypically distinct subsets of CD4+ T cells induce or protect
from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol 1993; 5: 1461-1471
14 Stokkers PC, Reitsma PH, Tytgat GN, van Deventer SJ. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a
meta-analysis. Gut 1999; 45: 395-401
15 Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR, Crawshaw J, Large O, de Silva A, Cook JT,
Barnardo M, Cullen S, Welsh KI, Jewell DP. The molecular classification of the clinical manifestations of Crohn's disease.
Gastroenterology 2002; 122: 854-866
16 Newman B, Silverberg MS, Gu X, Zhang Q, Lazaro A, Steinhart AH, Greenberg GR, Griffiths AM, McLeod RS, Cohen Z,
Fernandez-Vina M, Amos CI, Siminovitch K. CARD15 and HLA DRB1 alleles influence susceptibility and disease
localization in Crohn's disease. Am J Gastroenterol 2004; 99: 306-315
17 Fernandez L, Mendoza JL, Martinez A, Urcelay E, Fernandez-Arquero M, Garcia-Paredes J, Pena AS, Diaz-Rubio M, de
la Concha EG. IBD1 and IBD3 determine location of Crohn's disease in the Spanish population. Inflamm Bowel Dis 2004;
10: 715-722
18 Trachtenberg EA, Yang H, Hayes E, Vinson M, Lin C, Targan SR, Tyan D, Erlich H, Rotter JI. HLA class II haplotype
associations with inflammatory bowel disease in Jewish (Ashkenazi) and non-Jewish caucasian populations. Hum
Immunol 2000; 61: 326-333
19 Silverberg MS, Mirea L, Bull SB, Murphy JE, Steinhart AH, Greenberg GR, McLeod RS, Cohen Z, Wade JA, Siminovitch
KA. A population-and family-based study of Canadian families reveals association of HLA DRB1*0103 with colonic
involvement in inflammatory bowel disease. Inflamm Bowel Dis 2003; 9: 1-9
20 Matake H, Okabe N, Naito S, Yao T. An HLA study on 149 Japanese patients with Crohn's disease. Gastroenterol Jpn
1992; 27: 496-501
21 Nakajima A, Matsuhashi N, Kodama T, Yazaki Y, Takazoe M, Kimura A. HLA-linked susceptibility and resistance genes in
Crohn's disease. Gastroenterology 1995; 109: 1462-1467
22 Yoshitake S, Kimura A, Okada M, Yao T, Sasazuki T. HLA class II alleles in Japanese patients with inflammatory bowel
disease. Tissue Antigens 1999; 53: 350-358
23 de la Concha EG, Fernandez-Arquero M, Martinez A, Vigil P, Vidal F, Lopez-Nava G, Diaz-Rubio M, Garcia-Paredes J.
Amino acid polymorphism at residue 71 in HLA-DR beta chain plays a critical role in susceptibility to ulcerative colitis. Dig
Dis Sci 1999; 44: 2324-2329
24 Ahmad T, Armuzzi A, Neville M, Bunce M, Ling KL, Welsh KI, Marshall SE, Jewell DP. The contribution of human
leucocyte antigen complex genes to disease phenotype in ulcerative colitis. Tissue Antigens 2003; 62: 527-535
25 Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcon G, Ruiz-Morales JA, Higuera L, Cutino T, Rodriguez-Perez JM,
Villarreal-Garza C, Granados J. Clinical and genetic heterogeneity in Mexican patients with ulcerative colitis. Hum
Immunol 2003; 64: 119-123
26 Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S, Landers C, Jewell DP. Genetic markers may
predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997; 112: 1845-1853
27 Bouma G, Crusius JB, Garcia-Gonzalez MA, Meijer BU, Hellemans HP, Hakvoort RJ, Schreuder GM, Kostense PJ,
Meuwissen SG, Pena AS. Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol
1999; 115: 294-300
28 Futami S, Aoyama N, Honsako Y, Tamura T, Morimoto S, Nakashima T, Ohmoto A, Okano H, Miyamoto M, Inaba H. HLA-
DRB1*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig Dis Sci
1995; 40: 814-818
29 Myung SJ, Yang SK, Jung HY, Chang HS, Park B, Hong WS, Kim JH, Min I. HLA-DRB1*1502 confers susceptibility to
ulcerative colitis, but is negatively associated with its intractability: a Korean study. Int J Colorectal Dis 2002; 17: 233-
237
30 Masuda H, Nakamura Y, Tanaka T, Hayakawa S. Distinct relationship between HLA-DR genes and intractability of
ulcerative colitis. Am J Gastroenterol 1994; 89: 1957-1962
31 Seki SS, Sugimura K, Ota M, Matsuzawa J, Katsuyama Y, Ishizuka K, Mochizuki T, Suzuki K, Yoneyama O, Mizuki N,
Honma T, Inoko H, Asakura H. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated
with ulcerative colitis in Japanese. Tissue Antigens 2001; 58: 71-76
32 Kinouchi Y, Matsumoto K, Negoro K, Takagi S, Takahashi S, Hiwatashi N, Shimosegawa T. Hla-B genotype in Japanese
patients with Crohn's disease. Dis Colon Rectum 2003; 46: S10-14
33 Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA
genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology 2000; 118: 274-278
34 Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel
disease: clinical features and the role of HLA genes. Gastroenterology 2002; 123: 714-718
35 Rankin GB, Watts HD, Melnyk CS, Kelley ML, Jr. National Cooperative Crohn's Disease Study: extraintestinal
manifestations and perianal complications. Gastroenterology 1979; 77: 914-920
36 Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular
genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-1213
37 Newton J, Brown MA, Milicic A, Ackerman H, Darke C, Wilson JN, Wordsworth BP, Kwiatkowski D. The effect of HLA-DR
on susceptibility to rheumatoid arthritis is influenced by the associated lymphotoxin alpha-tumor necrosis factor
haplotype. Arthritis Rheum 2003; 48: 90-96
38 de la Concha EG, Fernandez-Arquero M, Vigil P, Rubio A, Maluenda C, Polanco I, Fernandez C, Figueredo MA. Celiac
disease and TNF promoter polymorphisms. Hum Immunol 2000; 61: 513-517
39 Fernandez-Arquero M, Arroyo R, Rubio A, Martin C, Vigil P, Conejero L, Figueredo MA, de la Concha EG. Primary
association of a TNF gene polymorphism with susceptibility to multiple sclerosis. Neurology 1999; 53: 1361-1363
40 Degli-Esposti MA, Abraham LJ, McCann V, Spies T, Christiansen FT, Dawkins RL. Ancestral haplotypes reveal the role
of the central MHC in the immunogenetics of IDDM. Immunogenetics 1992; 36: 345-356
41 Nomura E, Kinouchi Y, Negoro K, Kojima Y, Oomori S, Sugimura M, Hiroki M, Takagi S, Aihara H, Takahashi S, Hiwatashi
N, Shimosegawa T. Mapping of a disease susceptibility locus in chromosome 6p in Japanese patients with ulcerative
colitis. Genes Immun 2004; 5: 477-483
42 Kontoyiannis D, Pasparakis M, Pizarro TT, Cominelli F, Kollias G. Impaired on/off regulation of TNF biosynthesis in mice
lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies. Immunity 1999; 10: 387-
398
43 Neurath MF, Fuss I, Pasparakis M, Alexopoulou L, Haralambous S, Meyer zum Buschenfelde KH, Strober W, Kollias G.
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice. Eur J Immunol 1997; 27: 1743-
1750
44 van Heel DA, Udalova IA, De Silva AP, McGovern DP, Kinouchi Y, Hull J, Lench NJ, Cardon LR, Carey AH, Jewell DP,
Kwiatkowski D. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between
the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 2002; 11: 1281-1289
45 O'Callaghan NJ, Adams KE, van Heel DA, Cavanaugh JA. Association of TNF-alpha-857C with inflammatory bowel
disease in the Australian population. Scand J Gastroenterol 2003; 38: 533-534
46 Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, Sato H, Ling KL, Barnardo M, Goldthorpe
S, Walton R, Bunce M, Jewell DP, Welsh KI. Haplotype-specific linkage disequilibrium patterns define the genetic
topography of the human MHC. Hum Mol Genet 2003; 12: 647-656
47 Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, Shimosegawa T, Toyota T. Crohn's disease is
associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology 1999;
117: 1062-1068
48 Levine A, Karban A, Eliakim R, Shaoul R, Reif S, Pacht A, Wardi J, Yakir B, Silver EL. A polymorphism in the TNF-alpha
promoter gene is associated with pediatric onset and colonic location of Crohn's disease. Am J Gastroenterol 2005; 100:
407-413
49 Louis E, Peeters M, Franchimont D, Seidel L, Fontaine F, Demolin G, Croes F, Dupont P, Davin L, Omri S, Rutgeerts P,
Belaiche J. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?
Clin Exp Immunol 2000; 119: 64-68
50 Ferreira AC, Almeida S, Tavares M, Canedo P, Pereira F, Regalo G, Figueiredo C, Trindade E, Seruca R, Carneiro F,
Amil J, Machado JC, Tavarela-Veloso F. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's
disease. Inflamm Bowel Dis 2005; 11: 331-339
51 Bouma G, Xia B, Crusius JB, Bioque G, Koutroubakis I, Von Blomberg BM, Meuwissen SG, Pena AS. Distribution of four
polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp
Immunol 1996; 103: 391-396
52 Sashio H, Tamura K, Ito R, Yamamoto Y, Bamba H, Kosaka T, Fukui S, Sawada K, Fukuda Y, Tamura K, Satomi M,
Shimoyama T, Furuyama J. Polymorphisms of the TNF gene and the TNF receptor superfamily member 1B gene are
associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002; 53: 1020-
1027
53 Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T, Bukowski JF. MICA engagement by human Vgamma2Vdelta2 T
cells enhances their antigen-dependent effector function. Immunity 2001; 15: 83-93
54 Tieng V, Le Bouguenec C, du Merle L, Bertheau P, Desreumaux P, Janin A, Charron D, Toubert A. Binding of Escherichia
coli adhesin AfaE to CD55 triggers cell-surface expression of the MHC class I-related molecule MICA. Proc Natl Acad Sci
USA 2002; 99: 2977-2982
55 Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor
cells and activation of NK cells and macrophages. Nat Immunol 2000; 1: 119-126
56 Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, Spies T. Activation of NK cells and T cells by NKG2D, a receptor
for stress-inducible MICA. Science 1999; 285: 727-729
57 Steinle A, Li P, Morris DL, Groh V, Lanier LL, Strong RK, Spies T. Interactions of human NKG2D with its ligands MICA,
MICB, and homologs of the mouse RAE-1 protein family. Immunogenetics 2001; 53: 279-287
58 Ahmad T, Marshall SE, Mulcahy-Hawes K, Orchard T, Crawshaw J, Armuzzi A, Neville M, van Heel D, Barnardo M, Welsh
KI, Jewell DP, Bunce M. High resolution MIC genotyping: design and application to the investigation of inflammatory
bowel disease susceptibility. Tissue Antigens 2002; 60: 164-179
59 Glas J, Martin K, Brunnler G, Kopp R, Folwaczny C, Weiss EH, Albert ED. MICA, MICB and C1_4_1 polymorphism in
Crohn's disease and ulcerative colitis. Tissue Antigens 2001; 58: 243-249
60 Fdez-Morera JL, Rodrigo L, Lopez-Vazquez A, Rodero SR, Martinez-Borra J, Nino P, Gonzalez S, Lopez-Larrea C. MHC
class I chain-related gene A transmembrane polymorphism modulates the extension of ulcerative colitis. Hum Immunol
2003; 64: 816-822
61 Shiina T, Inoko H, Kulski JK. An update of the HLA genomic region, locus information and disease associations: 2004.
Tissue Antigens 2004; 64: 631-649
Answers to all your Biology Questions
